Beijing Scitop Bio Tech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 25.93%

Beijing Scitop Bio Tech Co Ltd (300858) has an Asset Resilience Ratio of 25.93% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥525.73 Million

≈ $76.93 Million USD Cash + Short-term Investments

Total Assets

CN¥2.03 Billion

≈ $296.66 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Beijing Scitop Bio Tech Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Beijing Scitop Bio Tech Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Beijing Scitop Bio Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300858 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥525.73 Million	25.93%
Total Liquid Assets	CN¥525.73 Million	25.93%

Asset Resilience Insights

Very High Liquidity: Beijing Scitop Bio Tech Co Ltd maintains exceptional liquid asset reserves at 25.93% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Beijing Scitop Bio Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Scitop Bio Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Beijing Scitop Bio Tech Co Ltd (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Beijing Scitop Bio Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.46%	CN¥110.21 Million ≈ $16.13 Million	CN¥2.02 Billion ≈ $295.43 Million	-10.03pp
2024-12-31	15.49%	CN¥296.73 Million ≈ $43.42 Million	CN¥1.92 Billion ≈ $280.31 Million	-19.61pp
2023-12-31	35.10%	CN¥635.26 Million ≈ $92.96 Million	CN¥1.81 Billion ≈ $264.87 Million	+19.39pp
2022-12-31	15.70%	CN¥281.17 Million ≈ $41.14 Million	CN¥1.79 Billion ≈ $262.01 Million	+6.91pp
2021-12-31	8.80%	CN¥91.55 Million ≈ $13.40 Million	CN¥1.04 Billion ≈ $152.29 Million	-8.06pp
2020-12-31	16.85%	CN¥168.40 Million ≈ $24.64 Million	CN¥999.25 Million ≈ $146.22 Million	--

pp = percentage points

About Beijing Scitop Bio Tech Co Ltd

SHE:300858 China Biotechnology

Market Cap

$545.20 Million

CN¥3.73 Billion CNY

Market Cap Rank

#11651 Global

#3270 in China

Share Price

CN¥14.14

Change (1 day)

+1.58%

52-Week Range

CN¥13.03 - CN¥25.45

All Time High

CN¥35.93